Probiotic<i>Escherichia coli</i>NISSLE 1917 for inflammatory bowel disease applications
Zejing Zhao, Shumin Xu, Wangyang Zhang, Danjun Wu, Gensheng Yang
Abstract
and enhances the ability of host immunity. In this review, the mechanisms of EcN in the remission of inflammatory bowel disease are proposed and recent advances on the functionalized EcN are compiled to provide novel therapeutic strategies for the prevention and treatment of IBD.
Topics & Concepts
ProbioticInflammatory bowel diseaseUlcerative colitisDiarrheaEscherichia coliImmune systemMedicineSecretionDiseaseColitisMicrobiologyImmunologyImmunityPathogenic bacteriaBacteriaBiologyGastroenterologyInternal medicineGeneticsBiochemistryGeneGut microbiota and healthProbiotics and Fermented FoodsInflammatory Bowel Disease